Navigation Links
Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory'
Date:12/15/2009

5='79322752';s.tl(this,'o','ExternalLink');" target='_blank' href="http://www.lowt.com/">Low T. Dr. Morgentaler notes that he has not personally treated Doug Barron.

In 2006 when controversy erupted about PGA 2003 Championship Winner Shaun Micheel's use of testosterone replacement therapy, Dr. Morgentaler explained to Sports Illustrated why Micheel's treatment should not be considered doping. After the PGA Tour last year adopted its Anti-Doping policy, it granted Micheel a therapeutic use exemption (TUE) for testosterone replacement therapy, but denied one to Barron -- even though both men have the same medical condition and neither has exceeded a normal testosterone range.

Tiger Woods commented in support of the PGA Tour's current Anti-Doping policy when Barron was suspended under it.

Unless the PGA Tour revises its current policy it could find itself still entangled in this Low T controversy come November 2010 when Micheel's present exemption expires. The PGA Tour will require Micheel to give up testosterone replacement therapy for a minimum of six to eight weeks and go through the blood-testing process again in order to get another exemption.

Micheel called the process he had to go through the last time "adversarial" and said that it "nearly drove me out of the game."

"The PGA Tour and other sports groups need to distinguish between the illegitimate use of high-dose anabolic steroids for performance enhancement and the perfectly legitimate, medically supervised use of FDA-approved medications to treat a serious condition that prevents a man from achieving his full, normal athletic potential," said Dr. Morgentaler.

"Doug Barron and Shaun Micheel simply happen to be among the
'/>"/>

SOURCE Slate Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Millar Instruments and Harvard Apparatus Improve Ability to Provide Customers With Total Physiology Solutions Through Joint Distribution Agreement
2. New Effort to Battle Antibiotic Resistance Rallies Researchers Throughout Harvard University
3. Stemgent Announces Sponsorship of Harvard Stem Cell Institute Seminar Series;
4. Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase
5. Harvard Study Shows Folic Acid, B Vitamins in Animi-3(R) May Prevent Vision Loss
6. BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University
7. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
8. Testosterone May Improve Mental Function, From the Harvard Mens Health Watch
9. Your Hearing May be at Risk, Says Harvard Mens Health Watch
10. For Most, Good Oral Care Does More Than Antibiotics to Prevent Dental-Related Heart Problems, Reports the Harvard Heart Letter
11. Tone Deafness Explained, from the Harvard Health Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... DENVER , June 18, 2013  Healthgrades, ... evaluate, compare and connect with physicians and hospitals, ... 2013: "Lean in" When Making Healthcare Decisions to ... the best performing hospitals for maternity care, gynecologic ... the treatment of women across 15 of the ...
(Date:6/18/2013)... Pharmaceuticals, Inc. (NASDAQ: ISIS ), the leader in ... corporate update in conjunction with its 2013 Annual Meeting of ... p.m. Pacific Time in Carlsbad, CA. ... 2:00 p.m. – 2:10 p.m. Annual Meeting of Stockholders (only ... p.m. – 3:15 p.m. Corporate Presentation – Stanley T. ...
(Date:6/17/2013)... -- DNAtrix Inc., experts in oncolytic virus development, today ... the company,s lead product, DNX-2401, at the Replicating Oncolytic ... on June 18, 2013. Dr. ... in the field of oncolytic virus therapy, will present ... TRIAL OF A CONDITIONALLY REPLICATION-COMPETENT ADENOVIRUS DNX-2401 (FORMERLY KNOWN ...
Breaking Medicine Technology:Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 3Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 4Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House 2DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus 2
... , - Partnership With ... Patients in California, Idaho, Indiana, Iowa, Maryland,Michigan and Ohio ... a world leader in healthcare and,medical publishing and online ... nation,s fourth largest Catholic health,system with 44 hospitals across ...
... /PRNewswire/ -- JumpStart Inc., the Northeast ... of high growth early-stage businesses, announced a JumpStart ... LLC. A spinout of NDI Medical, the Highland ... commercializing a surgical handheld disposable nerve stimulator. ...
Cached Medicine Technology:Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States 2Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States 3Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States 4JumpStart Invests in Checkpoint Surgical 2JumpStart Invests in Checkpoint Surgical 3
(Date:6/18/2013)... As obesity rates sky rocket in the ... equipment during childbirth comes as no shock. Forceps are surgical ... when she is unable to do so herself and although ... higher rates of complication for both the mother and the ... mother and child, forceps births add to the pressure of ...
(Date:6/18/2013)... SEATTLE, WA—A Washington state resident filed ... claiming he fell ill with a hepatitis A infection ... blend. The complaint was filed in Snohomish County ... Seattle-based law firm that has filed 14 previous ... complaint, Brian Brothers consumed “Townsend Farms Organic Antioxidant Blend” ...
(Date:6/18/2013)... The Drug Delivery Partnering Terms and Agreements ... drug delivery partnering deals and agreements entered into by ... provides a detailed understanding and analysis of how and ... of deals are discovery or development stage whereby the ... license the license drug delivery technology. These deals tend ...
(Date:6/18/2013)... The Temp1000IS temperature data logger is ... be used to automatically record temperatures between -20 and ... comes with the serial number and device name engraved. ... separately) docking station and can be placed directly into ... of end-caps to download data. The small size of ...
(Date:6/18/2013)... 2013 Parker Waichman LLP , ... of victims injured by defective medical devices, reports that ... Infuse bone graft products are now available. Published this ... the two studies serve up two key findings: There ... Infuse and the traditional bone graft; and there is ...
Breaking Medicine News(10 mins):Health News:Forceps Births Double, Obesity is Major Reason in Births Complications 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 2Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 4Health News:MadgeTech, Inc. Introduces the New Temp1000IS Intrinsically Safe High Temperature Data Logger 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 3
... the fight against HIV and they must be given ... a new commentary published today in the journal Nature ... who are evaluating multiple candidate vaccines designed to prevent ... commit to sharing technology and expertise with those in ...
... Tufts University School of Medicine in collaboration with ... created a computer program called Pathogen Simulation (PathSim) ... in humans. David Thorley-Lawson, PhD, professor of pathology ... PathSim, laboratory methods, and clinical studies to provide ...
... MA- Mayor Michael R. Bloomberg of New York ... Julius B. Richmond Award, the highest honor given by ... of bold initiatives that recognize public health as a ... extraordinary leadership in protecting and promoting the health of ...
... is the latest American Chemical Society (ACS) News Service ... journals and Chemical & Engineering News. With more than,160,000 ... the individual journal, or the American Chemical Society, as ... #1 FOR IMMEDIATE RELEASE , , Excess female ...
... at the University of Pennsylvania School of Medicine have ... affecting the prognosis of patients with head and neck ... issue of CANCER. , The belief that a patients ... their cancer is one that has been prominent among ...
... 100,000 California seniors finds too few health tests , ... care received by vulnerable elderly Medicare, Medicaid patients is ... Researchers at the University of California, Los Angeles, used ... of Vulnerable Elders project to look at 43 specific ...
Cached Medicine News:Health News:Fight against HIV needs local scientists, say researchers 2Health News:Epstein-Barr: a virtual look at a vexing virus 2Health News:Bloomberg receives award for promotion of health in NYC and nation 2Health News:Bloomberg receives award for promotion of health in NYC and nation 3Health News:Bloomberg receives award for promotion of health in NYC and nation 4Health News:American Chemical Society's Weekly Presspac -- Oct. 17, 2007 2Health News:American Chemical Society's Weekly Presspac -- Oct. 17, 2007 3Health News:American Chemical Society's Weekly Presspac -- Oct. 17, 2007 4Health News:American Chemical Society's Weekly Presspac -- Oct. 17, 2007 5Health News:American Chemical Society's Weekly Presspac -- Oct. 17, 2007 6Health News:American Chemical Society's Weekly Presspac -- Oct. 17, 2007 7Health News:American Chemical Society's Weekly Presspac -- Oct. 17, 2007 8Health News:Penn researchers find emotional well-being has no influence on cancer survival 2Health News:Most Elderly Don't Get Good Medical Care: Study 2
VersaStep™ Reposable Sterilization Trays....
... The Open-Step™ single-use system device is comprised ... for creating each access port are also ... 12 mm locking cone with 12 mm ... sterile; The 12 mm locking cone ...
... device components are supplied sterile. , ,The ... supplied sterile in 2/3, 5, 7/8, 10 and ... combinations. They are used in conjunction with the ... radially Expandable Sleeve. The 5, 7/8, 10 and ...
... V2 RT single-use obturator has a sharp linear ... ,The Auto Suture™ VERSAPORT™ PLUS V2 RT single-use ... mm and 12 mm diameters with a shield ... mm short single-use obturators are not available with ...
Medicine Products: